Healthcare provider profile · identity verified

Manu Sehgal, M.D.

Internal Medicine · MILFORD, DE · NPI 1447322060

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	930	231
Atorvastatin Calcium	Atorvastatin Calcium	912	229
Losartan Potassium	Losartan Potassium	762	211
Levothyroxine Sodium	Levothyroxine Sodium	612	143
Rosuvastatin Calcium	Rosuvastatin Calcium	578	157
Olmesartan Medoxomil	Olmesartan Medoxomil	492	149
Metoprolol Succinate	Metoprolol Succinate	464	118
Gabapentin	Gabapentin	390	104
Pantoprazole Sodium	Pantoprazole Sodium	368	95
Metformin Hcl	Metformin Hcl	347	97
Lisinopril	Lisinopril	333	100
Hydrochlorothiazide	Hydrochlorothiazide	329	93
Omeprazole	Omeprazole	319	75
Escitalopram Oxalate	Escitalopram Oxalate	311	73
Tamsulosin Hcl	Tamsulosin Hcl	309	75
Eliquis	Apixaban	301	63
Furosemide	Furosemide	297	97
Carvedilol	Carvedilol	233	52
Memantine Hcl	Memantine Hcl	213	27
Metoprolol Tartrate	Metoprolol Tartrate	211	59
Glimepiride	Glimepiride	192	54
Alendronate Sodium	Alendronate Sodium	189	50
Allopurinol	Allopurinol	169	40
Finasteride	Finasteride	152	31
Sertraline Hcl	Sertraline Hcl	151	38
Trazodone Hcl	Trazodone Hcl	146	35
Pravastatin Sodium	Pravastatin Sodium	138	42
Simvastatin	Simvastatin	136	36
Jardiance	Empagliflozin	133	34
Clopidogrel	Clopidogrel Bisulfate	118	28
Duloxetine Hcl	Duloxetine Hcl	114	34
Donepezil Hcl	Donepezil Hcl	104	23
Ozempic	Semaglutide	102	28
Potassium Chloride	Potassium Chloride	99	26
Tramadol Hcl	Tramadol Hcl	98	31
Alprazolam	Alprazolam	96	30
Montelukast Sodium	Montelukast Sodium	93	22
Synthroid	Levothyroxine Sodium	93	23
Atenolol	Atenolol	92	24
Famotidine	Famotidine	90	26
Mirtazapine	Mirtazapine	90	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	83	22
Citalopram Hbr	Citalopram Hydrobromide	75	18
Valsartan	Valsartan	75	18
Albuterol Sulfate Hfa	Albuterol Sulfate	70	32
Bumetanide	Bumetanide	70	15
Venlafaxine Hcl Er	Venlafaxine Hcl	70	16
Fluticasone Propionate	Fluticasone Propionate	69	38
Farxiga	Dapagliflozin Propanediol	64	15
Metformin Hcl Er	Metformin Hcl	63	22
Buspirone Hcl	Buspirone Hcl	62	21
Prednisone	Prednisone	61	30
Rexulti	Brexpiprazole	60	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	60	22
Meclizine Hcl	Meclizine Hcl	58	30
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	12
Fluoxetine Hcl	Fluoxetine Hcl	54	12
Ipratropium Bromide	Ipratropium Bromide	52	18
Glipizide Er	Glipizide	51	13
Trulicity	Dulaglutide	51	16
Celecoxib	Celecoxib	50	20
Clonazepam	Clonazepam	48	14
Enalapril Maleate	Enalapril Maleate	48	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	48	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	suppressed
Hydrocortisone	Hydrocortisone	46	suppressed
Mounjaro	Tirzepatide	43	11
Hydralazine Hcl	Hydralazine Hcl	39	14
Esomeprazole Magnesium	Esomeprazole Magnesium	38	12
Spironolactone	Spironolactone	38	suppressed
Lovastatin	Lovastatin	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	11
Warfarin Sodium	Warfarin Sodium	37	suppressed
Baclofen	Baclofen	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Meloxicam	Meloxicam	34	15
Myrbetriq	Mirabegron	33	13
Ondansetron Hcl	Ondansetron Hcl	33	19
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Topiramate	Topiramate	31	suppressed
Ondansetron Odt	Ondansetron	30	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Azelastine Hcl	Azelastine Hcl	29	15
Ezetimibe	Ezetimibe	28	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	14
Olanzapine	Olanzapine	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Estradiol	Estradiol	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Azithromycin	Azithromycin	24	22
Glipizide	Glipizide	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Methylprednisolone	Methylprednisolone	24	23
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Clonidine Hcl	Clonidine Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	22	suppressed
Cephalexin	Cephalexin	22	17
Levetiracetam	Levetiracetam	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	22	suppressed
Risperidone	Risperidone	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	19
Pregabalin	Pregabalin	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Ranolazine Er	Ranolazine	19	suppressed
Brilinta	Ticagrelor	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Tramadol Hcl Er	Tramadol Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Digoxin	Digoxin	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Mupirocin	Mupirocin	17	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	16	suppressed
Amoxicillin	Amoxicillin	15	11
Erythromycin	Erythromycin Base	15	suppressed
Temazepam	Temazepam	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Nystatin	Nystatin	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Gemtesa	Vibegron	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Mesalamine Er	Mesalamine	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Irbesartan	Irbesartan	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error